Form D · Biotechnology

Grove Biomedical LLC

Katonah, NY · CIK 0001823771

Offering snapshot reported Mar 18, 2022 · SEC filing

Reported sold
$950K
Offering amount: $1M
Investors reported
7
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 10, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$475K$950KDec 17, 2020: $150,000.00Dec 17, 2020Mar 18, 2022: $950,000.00Mar 18, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$150,000 → $950,000
  • Reported investors0 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 18, 2022Amendment$950,000$800,000vs Dec 17, 20207SEC filing
Feb 10, 2022Initial$300,000No comparison1SEC filing
Dec 17, 2020Initial$150,000No comparison0SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-383488

Source: Form D, filed Mar 18, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Rosenberg Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
282 Katonah Avenue #537
Katonah, NY, 10536